Link Medicine Raises $40 Million
Link Medicine Corp., a Cambridge, Mass.-based developer of disease-modifying therapies for neurodegenerative indications, has raised $40 million in Series C funding co-led by Clarus Ventures and SV Life Sciences.
30 September 2008•4 mins read
